This invention relates to the field of
biopharmaceutical technology, and particularly to a method for extracting unimodal
human chorionic gonadotropin (hCG) from human
urine. The method includes: loading
urine from a healthy pregnant woman onto a YKW214 resin
chromatography column, treating it with a washing buffer and eluent containing
sodium chloride, and collecting the eluent;
ultrafiltration and desalting to obtain a first ultrafiltrate; adjusting the pH and loading it onto a
monoclonal antibody chromatography column with a ligand specifically binding to an HCG β
subunit antibody, washing and eluting, and collecting the eluent;
ultrafiltration and desalting again to obtain a second ultrafiltrate; performing
virus-free
filtration; adjusting the pH and loading it onto an RPC15
chromatography column, selectively removing HCG containing only the β
subunit by utilizing the difference in the number of hydrophobic amino acids between intact HCG molecules and free β subunits, collecting the eluent; adding
ethanol for
precipitation, centrifuging, and
vacuum drying to obtain unimodal hCG. This method effectively removes impurities such as free β subunits, resulting in a product with high purity, high yield, good safety, simple operation, and suitability for large-scale production.